SG/CALL/ROCHE GS/320/0.1/20.09.24 Share Price

Warrant

DE000SW13PG9

Delayed Deutsche Boerse AG 04:44:49 21/05/2024 pm IST
0.065 EUR +75.68% Intraday chart for SG/CALL/ROCHE GS/320/0.1/20.09.24
Current month+76.19%
1 month-5.13%
Date Price Change
21/24/21 0.065 +75.68%
20/24/20 0.037 -2.63%
17/24/17 0.038 -50.65%
16/24/16 0.077 +165.52%
15/24/15 0.029 +31.82%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 04:44 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SW13PG
ISINDE000SW13PG9
Date issued 10/08/2023
Strike 320 CHF
Maturity 20/09/2024 (123 Days)
Parity 10 : 1
Emission price 0.59
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.52
Lowest since issue 0.001
Delta0.05x
Omega 15.39
Premium35.89x
Gearing340.95x
Moneyness 0.7375
Difference Strike 84.05 CHF
Difference Strike %+26.27%
Spread 0.01
Spread %13.33%
Intrinsic value 0.000000

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW